Abstract. Both peripheral innervation and nitric oxide (NO) participate in ovarian steroidogenesis. The purpose of this work was to analyse the ganglionic adrenergic influence on the ovarian release of steroids and NO and the possible steroids/ NO relationship. The experiments were carried out in the ex vivo coeliac ganglion-superior ovarian nerve (SON)-ovary system of prepubertal rats. The coeliac ganglion-SON-ovary system was incubated in Krebs Ringer-bicarbonate buffer in presence of adrenergic agents in the ganglionic compartment. The accumulation of progesterone, androstenedione, oestradiol and NO in the ovarian incubation liquid was measured. Norepinephrine in coeliac ganglion inhibited the liberation of progesterone and increased androstenedione, oestradiol and NO in ovary. The addition of α and β adrenergic antagonists also showed different responses in the liberation of the substances mentioned before, which, from a physiological point of view, reveals the presence of adrenergic receptors in coeliac ganglion. In relation to propranolol, it does not revert the effect of noradrenaline on the liberation of progesterone, which leads us to think that it might also have a "per se" effect on the ganglion, responsible for the ovarian response observed for progesterone. Finally, we can conclude that the ganglionic adrenergic action via SON participates on the regulation of the prepubertal ovary in one of two ways: either increasing the NO, a gaseous neurotransmitter with cytostatic characteristics, to favour the immature follicles to remain dormant or increasing the liberation of androstenedione and oestradiol, the steroids necessary for the beginning of the near first estral cycle. AT present, there is clear evidence that ovarian steroidogenesis, besides being regulated by the classic hypothalamo-hypophyseal-ovarian axis, is influenced by the neural pathway. The main neural information reaches the ovaries by the hilium via the superior ovarian nerve and ovarian plexus [1, 2] . Hirshfield [3] confirmed that the first follicles to start growing are those assembled near the ovarian hilium, the first region in the ovaries of the rat to be innervated during its fetoneonatal life [4] . The sympathetic innervation terminals are closely related to the steroidogenic ovarian cells [5] , and peptidergic and catecholaminergic neurotransmitters, mainly norepinephrine [6] [7] [8] , are released from the superior ovarian nerve (SON) to the ovary. Both peptides and norepinephrine act via adenylate cyclase coupled receptors that are present in the ovary at the beginning of the folliculogenesis [9, 10] . Several experimental designs have been used to investigate the role of innervation in the control of the ovarian function of prepubertal rat. In this respect, it has been reported in ovarian cell culture that the effect of adrenergic agents depends on the number of betareceptor sites present in the ovaries of pre and peripubertal rats [11] .
AT present, there is clear evidence that ovarian steroidogenesis, besides being regulated by the classic hypothalamo-hypophyseal-ovarian axis, is influenced by the neural pathway. The main neural information reaches the ovaries by the hilium via the superior ovarian nerve and ovarian plexus [1, 2] . Hirshfield [3] confirmed that the first follicles to start growing are those assembled near the ovarian hilium, the first region in the ovaries of the rat to be innervated during its fetoneonatal life [4] .
The sympathetic innervation terminals are closely related to the steroidogenic ovarian cells [5] , and peptidergic and catecholaminergic neurotransmitters, mainly norepinephrine [6] [7] [8] , are released from the superior ovarian nerve (SON) to the ovary. Both peptides and norepinephrine act via adenylate cyclase coupled receptors that are present in the ovary at the beginning of the folliculogenesis [9, 10] . Several experimental designs have been used to investigate the role of innervation in the control of the ovarian function of prepubertal rat. In this respect, it has been reported in ovarian cell culture that the effect of adrenergic agents depends on the number of betareceptor sites present in the ovaries of pre and peripubertal rats [11] .
Experiments carried out by our group have shown that the bilateral transection of the neonatal SON leads to a delay in the vaginal opening, a modification in the circulating levels of FSH, prolactin and GH and an increase of the circulating oestradiol [12] . Besides, Delgado et al. [13] , working with the integrated ex vivo coeliac ganglion-SON-ovary in prepubertal rat, showed that the cholinergic ganglion stimulation modifies the liberation of ovarian steroids.
It is well known that the principal structure in the ovary of prepubertal rat is the immature follicle in which the thecal layer is the principal site for the production of progestagens. On the other hand, the theca and secondary interstitial cells of the ovarian stroma are responsible for the synthesis of androgens [1, 2, 14, 15] .
Androstenedione plays an important role in the physiology of the ovary since it is involved in the synthesis of oestradiol, in the determination of the follicles that will be atretic [5] and in the maintenance of the corpora lutea by its transformation into intraluteal oestradiol [16] . Moreover, in short periods androstenedione itself causes progesterone release from luteal cells in culture [17] .
A further factor related to the synthesis of ovarian steroids is nitric oxide (NO), a diffusible gas considered to act as a neurotransmitter and biological mediator of the neuroendocrine axis. A great deal of evidence of NO participation in reproduction control has been reported [13, [18] [19] [20] .
Thus, the coeliac ganglion, via the SON, and NO participate in ovarian steroidogenesis. Besides, in our previous work we stated that the coeliac ganglion in presence of cholinergic agents participates in steroidogenesis partly because of NO liberation [13] . The purpose of this work is to analyse the ganglionic adrenergic influence on the ovarian release of progesterone, androstenedione, oestradiol and NO, and to evaluate the possible steroids/NO relationship. In both cases, the analysis is carried out in the ex vivo coeliac ganglion-SON-ovary system of prepubertal rats.
Materials and Methods

Animals
Virgin Holtzman strain female prepubertal rats of 30 days of age (60 ± 10 g body weight) were used in all the experiments. The rats were kept under controlled conditions with lights on from 0700 to 1900 h and at a temperature of 24 ± 2°C. Animals had free access to food (Cargill SACI, Saladillo, Buenos Aires, Argentina), and tap water was available ad libitum. Groups of six animals were used for the experimental procedure.
The experiments were performed in accordance with the UFAW Handbook on the Care and Management of Laboratory Animals, volume 1 -Terrestrial vertebrates -seventh edition, edited by: Trevor Poole (1999) and the Guide for Animal Use and Handling of the National University of San Luis, Argentina.
Reagents
The following drugs: L-D-norepinephrine hydrochloride (NE), phentolamine hydrochloride (Ph), Lpropranolol hydrochloride (Prop), dextrose, ascorbic acid, bovine serum albumin fraction V (BSA), sulfanilamide and N-1-naphthyl-ethylenediamine, were purchased from the Sigma Chemical Co (St. Louis, Mo, USA 
Experimental procedure
The surgical procedure used for removing the system and its characterization were performed as described previously [13] . Briefly, a piece of tissue containing the left ovary, the fibres that constitute the superior ovarian nerve and the coeliac ganglion were removed. The strip of tissue was carefully dissected avoiding contact between the surgical instruments and the nerve fibres or the ganglion in order to prevent spontaneous depolarisation of the nerves. The total surgical procedure was completed in 1-2 min. The coeliac ganglion-SON-ovary system was washed with the incubation medium and placed immediately in the cuvette consisting of two compartments. Each cuvette contained 1 ml of Krebs-Ringer bicarbonate buffer, pH 7.4 solution, in the presence of dextrose (0.1 mg/ml) and BSA (0.1 mg/ ml). The ganglion was placed in a compartment and the ovary in the other one, both joined by the SON, which had to remain humid with the work solution. The system was stabilized by preincubation in metabolic bath at 37°C for 15 min in an atmosphere composed by 95% O 2 and 5% CO 2 . The end of the preincubation period was considered as incubation time 0. At this time, the buffer was changed in both compart-ments; ascorbic acid (0.1 mg/ml in Krebs-Ringer) was added as an antioxidant agent to the ganglionic compartment.
Hormonal and NO determinations were measured in the same ovarian incubation liquid. The values of progesterone, androstenedione, oestradiol and nitrite a water soluble metabolite of nitric oxide, released under these conditions were considered to be the control (control groups). The adrenergic agents (experimental groups) used were: norepinephrine-adrenergic agonist, phentolamine-α antagonist and propranolol-β antagonist. The different substances were dissolved in equal concentrations (10 -6 M) and volumes (1 ml) of KrebsRinger solution plus ascorbic acid. The adrenergic agents were added to the ganglion compartment.
The samples of liquid from the ovarian compartment (250 µl) were collected at 15, 30, 60 and 120 min from the beginning of the incubation. These were kept at -20°C until the determination of progesterone, androstenedione and oestradiol by radioimmunoassay (RIA) and nitrite by Griess method. The respective corrections were made in all cases considering the volume in each period tested.
Steroids assay
Progesterone, androstenedione and oestradiol were measured by RIA [21] . The sensitivity of the progesterone assay was less than 5 ng/ml, that of androstenedione assay was less than 0.01 ng/ml and that of oestradiol assay was 2.2 pg/ml. The inter and intraassay coefficients of variation for all the assays were less than 10.0%.
The results were expressed as nanograms of progesterone per milligram of ovarian tissue (ng/mg ovary) and picograms of androstenedione and oestradiol per milligram of ovarian tissue (pg/mg ovary).
Nitrite assay
Levels of nitrite, a water-soluble metabolite of nitric oxide, were measured spectrophotometrically [22] . Briefly, samples were mixed with Griess reagent (sulfanilamide with N-1-naphthyl-ethylenediamine/HCl). After a 10 minute incubation period at room temperature, they were read for absorbance of 540 nm. The assay sensitivity was less than 2.5 nmol/ml. The intraassay coefficients of variation for all the assays were less than 10.0%.
The results were expressed as nanomol of nitrite per milligram of ovarian tissue (nmol/mg ovary).
Statistical analysis
Results are presented as mean ± SEM in each group. Student's t-test was used to assay significant differences between means of two groups. Analysis of the variances (ANOVA) followed by Tau's multiple range test was used for several comparisons. A value of p< 0.05 was accepted as statistically significant [23] .
Results
The control values of progesterone, androstenedione and nitrites have been published in Delgado et al. [13] and confirmed in the present work.
Effect of addition of adrenergic agents to the ganglion compartment on release of ovarian steroids
Progesterone
The presence of adrenergic agonist norepinephrine (NE) in the ganglion compartment diminished the release of progesterone at all the studied times (*p<0.01) compared with the control group (Fig. 1A-a) .
Phentolamine-α antagonist (Ph) diminished the release of ovarian progesterone compared with the control group at 60 and 120 min ( • p<0.05). Propranolol-β antagonist (Prop) in the ganglion compartment diminished the release of ovarian progesterone until 60 min ( • p<0.05) and at 120 min (*p<0.01) compared with the control group (Fig. 1A-b) .
Androstenedione
The presence of norepinephrine in the ganglion compartment increased the release of androstenedione compared with the control group, at 15 and 30 min ( • p<0.05); 60 min (*p<0.01) (Fig. 1B-a) .
Phentolamine increased the release of androstenedione at 15 and 60 min (*p<0.01), 30 min ( • p<0.05) and diminished it at 120 min ( • p<0.05). Propranolol in the ganglion compartment diminished the release of ovarian androstenedione at 15 and 30 min ( • p<0.05) and at 120 min (*p<0.01) (Fig. 1B-b) .
Oestradiol
The presence of norepinephrine in the ganglion com- partment increased the release of ovarian oestradiol compared with the control group at all the studied times (*p<0.01) (Fig. 1C-a) . Phentolamine in the ganglion compartment inhibited the release of oestradiol at 15 and 30 min (*p<0.01) and at 60 min ( • p<0.05) compared with the control group. Propranolol only caused a significant decrease of oestradiol at 15 and 30 min (*p<0.01) (Fig. 1C-b) .
Effect of addition of adrenergic agents to the ganglion compartment on release of nitrites
When the release of nitrites was analysed, norepinephrine in coeliac ganglion increased the nitrites at 15, 30 and 60 min ( • p<0.05) compared with the control group ( Fig. 2-a) .
Phentolamine in the ganglion compartment increased the release of nitrites in the ovarian compartment only at 15 min ( • p<0.05) whereas Propranolol (Prop) diminished it at all the studied times compared with the control group (*p<0.01) (Fig. 2-b ).
Discussion
Our previous investigations have shown that the stimulation of the coeliac ganglion with cholinergic agents modifies the liberation of ovarian steroids in prepubertal rat [13] .
It is well known that the coeliac ganglion-mesenteric complex is also innervated by fibres of an adrenergic nature that come from other preaortic ganglia, and that it exhibits α and β adrenergic receptors [24, 25] . The presence of such receptors in coeliac ganglion was demonstrated physiologically in adult rats [8, 26] .
The purpose of the present work was to analyse in prepubertal rats the adrenergic ganglionic effect on the liberation of ovarian steroids and NO, and to evaluate the possible steroids/NO relationship. The integrated ex vivo coeliac ganglion-SON-ovary system previously standardized in our laboratory was used.
The presence of norepinephrine in the ganglion compartment inhibited the liberation of progesterone, while it increased the accumulation of both androstenedione and oestradiol compared with their respective control groups. Our results are supported by those obtained by Rosa-e-Silva et al. [27] who showed, by chemical sympathectomy during prepuberty, that androgen biosynthesis is blocked with the subsequent progesterone increase.
Although in our system the adrenergic agent was added in ganglion, it is necessary to take into account that at the terminals level from SON to the ovary norepinephrine is liberated, and it coliberates with other neurotransmitters such as NPY [28] , GABA [29] and VIP [30] . There are antecedents revealing that the neurotransmitters have an important function in facilitating the initial differentiation of the granulose cells, thus promoting the acquisition of dependence from the gonadotrophins [31, 32] . As the presence of β-adrenergic receptors has been characterized in different populations of ovarian cells [11] , and their occupation with adrenergic agonists induces modification in the liberation of the ovarian steroids [11, 33] , it is possible to think that in the studied system the catecholamines released from the SON by ganglionic adrenergic stimulus act directly on the ovarian interstitial cells and modulate the production of androgens through the β 2 receptors [12, 33, 34] . In ovaries of immature rats, the activity of the 5-α reductase enzyme that catalyses the reduction of androgens is increased. According to Karakawa et al. [35] , an alternative way of adrenergic action could be the inhibition of this enzyme activity. If the enzymatic activity was diminished, the increase of androstenedione by ganglionic adrenergic effect would be partly explained.
In relation to oestradiol, Davoren and Hsueh (1985) [30] have demonstrated that VIP has a stimulating effect on its production in in vitro studies in granulose cells of immature rats. This effect might be due to the stimulation of the P450 aromatase activity, an enzyme of oestrogen synthesis. The VIP effects seem to be at least partly cAMP-dependent and may be mediated through stereospecific ovarian recognition sites. According to these authors, the accumulation of intra and extracellular cAMP in granulose cells incubation with VIP increases at 15 min (intracellular) and at 30 min (extracellular), and it is maintained during the incubation time (24 hs). On the other hand, in incubations of neonatal rats ovaries, VIP exerts a stimulating effect causing an increase in the FSH receptors content in immature follicles, an increase in the expression of the mRNA encoding it and an increase in the response to FSH via cAMP. These findings are made evident only at prolonged times [36] . According to these antecedents, it is possible that part of these mechanisms start activating themselves within the incubation times of our system in relation to the liberation of oestradiol.
NO is a neurotransmitter, located in the ovary, that modulates the steroidogenesis [37, 38] . In our study, we observed an increase in the levels of nitrite, a soluble metabolite of NO, and an inhibition in the liberation of ovarian progesterone, both of them caused by ganglionic adrenergic stimulus. The inhibition of progesterone might be partly due to the increase of NO. These results agree with those obtained in our previous work with cholinergic stimulus. The results of that experience [13] showed that, using the some system, cholinergic stimuli also brought about an increase of NO and a decrease of progesterone with a very similar time course pattern as that observed by adrenergic stimuli in the present study.
It is necessary to emphasize that the increase of NO by ganglionic adrenergic stimulus is lower than that observed by cholinergic stimulus [13] , which led us to think that the inhibitory effect of NO only occurs on the most sensitive steroid to the neural action [11] .
If we assume that the coeliac ganglion-SON-ovary system constitutes a viable and functional entity with its own autonomic tone, we can use antagonists in coeliac ganglion without the simultaneous addition of the agonist as observed in other stages [8, 26, 39] .
The addition of α and β adrenergic antagonists to the ganglion compartment showed different responses in the liberation of steroids and NO at ovarian level. From a physiological point of view, the results obtained with the addition of adrenergic agents reveal the presence of adrenergic receptors in the coeliac ganglion.
Although propranolol has an antagonistic effect in relation to noradrenaline on the liberation of androstenedione, oestradiol and nitric oxide, this effect was not observed for progesterone. In order to explain the effect observed on the liberation of progesterone, it is important to emphasize that propranolol, besides being a β adrenergic antagonist, has been shown to have a "per se" effect in interstitial testicular cells as suggested by Wanderley et al. [40] , which leads us to suggest that propranolol might also have a "per se" effect on the ganglion.
Besides, recent investigations carried out by our research group indicate that the neural stimulus on the ganglion causes an increase of GnRH in the ovarian compartment in the same in vitro system (these data have not been shown in this work). In relation to GnRH, Matsumi et al. [20] have shown that the administration of a GnRH agonist to immature rats and the treatment with the same agonist of granulose cells in culture cause a decrease in the levels of mRNA of the inducible nitric oxide synthase isoform, the synthesis enzyme of the nitric oxide. In addition, Yang et al. [41] have found similar results in rats in the eighth day of pregnancy, not only in in vivo studies but also in luteal cell cultures. They have also observed a decrease in the serum levels and in the luteal production and liberation of pregnenolone and progesterone.
The previously described antecedents leads us to suggest that if propanolol exerted a per se effect on the ganglion, this might be responsible for the increase of GnRH in the ovary, which would probably inhibit, in part, the nitric oxide and the liberation of progesterone. However, additional studies are necessary to substantiate such suggestion, a research we are currently carrying out.
Finally, we can conclude that the ganglionic adrenergic action via SON participates on the regulation of the prepubertal ovary in one of two ways: either increasing the NO, a gaseous neurotransmitter with cytostatic characteristics, to favour the immature follicles to remain dormant or increasing the liberation of androstenedione and oestradiol, the steroids necessary for the beginning of the near first estral cycle.
